Literature DB >> 3107348

Cisternal and lumbar CSF levels of arachidonate metabolites after subarachnoid haemorrhage: an assessment of the biochemical hypothesis of vasospasm.

R Rodriguez y Baena, P Gaetani, V Silvani, T Viganò, M T Crivellari, P Paoletti.   

Abstract

Several naturally occurring compounds have been identified in human cerebrospinal fluid (CSF) after subarachnoid haemorrhage (SAH) as possible vasoactive agents involved in the biochemical mechanism of vasospasm. The authors have measured, in 30 patients admitted for SAH, CSF concentrations of two arachidonic acid metabolites. Prostacyclin and Prostaglandin D2, as representative of vasodilator and vasoconstrictor compounds. CSF samples were made available by lumbar punctures and intraoperative cisternal punctures. Nine patients presented with symptomatic vasospasm: lumbar CSF Prostaglandin D2 levels are significantly higher than in patients without vasospasm. The Cisternal Prostaglandin D2 level is significantly higher than the lumbar CSF concentration; CSF Prostacyclin levels do not significantly differ in the two groups of patients. These data suggest the presence of an imbalanced biochemical situation responsible for promoting vasospasm. The evaluation of cisternal levels of arachidonate metabolites support the hypothesis of the clotting phenomenon around the ruptured aneurysm wall as an important predictive pattern of vasospasm onset after SAH, as shown in computed tomography.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3107348     DOI: 10.1007/bf01418838

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  34 in total

1.  Surgical risk as related to time of intervention in the repair of intracranial aneurysms.

Authors:  W E Hunt; R M Hess
Journal:  J Neurosurg       Date:  1968-01       Impact factor: 5.115

2.  Prostacyclin and cerebral vessel relaxation.

Authors:  K S Paul; E T Whalley; C Forster; R Lye; J Dutton
Journal:  J Neurosurg       Date:  1982-09       Impact factor: 5.115

3.  Effect of leucotrienes C4, D4, prostacyclin and thromboxane A2 on isolated human cerebral arteries.

Authors:  H von Holst; E Granström; S Hammarström; B Samuelsson; L Steiner
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

4.  Role of intrinsic arachidonate metabolites in the vascular action of erythrocyte breakdown products.

Authors:  S Okamoto; H Handa; N Toda
Journal:  Stroke       Date:  1984 Jan-Feb       Impact factor: 7.914

5.  Lipid peroxidation as a cause of cerebral vasospasm.

Authors:  K Sano; T Asano; T Tanishima; T Sasaki
Journal:  Neurol Res       Date:  1980       Impact factor: 2.448

6.  Subarachnoid hemorrhage from intracranial aneurysms. Surgical management and natural history of disease.

Authors:  T M Sundt; J P Whisnant
Journal:  N Engl J Med       Date:  1978-07-20       Impact factor: 91.245

7.  Prevention of vasospasm by early operation with removal of subarachnoid blood.

Authors:  M Mizukami; T Kawase; T Usami; T Tazawa
Journal:  Neurosurgery       Date:  1982-03       Impact factor: 4.654

8.  Correlation between CT findings and subsequent development of cerebral infarction due to vasospasm in subarachnoid haemorrhage.

Authors:  J Suzuki; S Komatsu; T Sato; Y Sakurai
Journal:  Acta Neurochir (Wien)       Date:  1980       Impact factor: 2.216

9.  Vasospasm assessed by angiography and computerized tomography.

Authors:  I Saito; T Shigeno; K Aritake; T Tanishima; K Sano
Journal:  J Neurosurg       Date:  1979-10       Impact factor: 5.115

10.  Cerebral vasospasm with ruptured saccular aneurysm--the clinical manifestations.

Authors:  C M Fisher; G H Roberson; R G Ojemann
Journal:  Neurosurgery       Date:  1977 Nov-Dec       Impact factor: 4.654

View more
  1 in total

1.  Elucidating novel mechanisms of brain injury following subarachnoid hemorrhage: an emerging role for neuroproteomics.

Authors:  Melanie D King; Melissa D Laird; Sangeetha Sukumari Ramesh; Patrick Youssef; Basheer Shakir; John R Vender; Cargill H Alleyne; Krishnan M Dhandapani
Journal:  Neurosurg Focus       Date:  2010-01       Impact factor: 4.047

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.